can glp 1 hurt your kidneys Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria Could a GLP-1 Agonist Be

Currently, nearly 10 million (1 in 4) patients with diabetes have diabetic retinopathy (DR) in the United States, with 5% (1.84 million) having vision-threatening disease

In contrast, GLP-1 agonists typically produce more substantial glycemic improvements and consistent, clinically significant weight loss

Hormonal stability, lean mass preservation through strength training, and baseline metabolic data all shape how the body responds to medication

It is a medical necessity

Appropriately counsel patients who are switching between weight-loss medications

GLP-1 medications work with your bodys natural systems, ensuring steady, long-term weight loss without drastic side effects